Your session is about to expire
← Back to Search
Beta Blocker De-prescription After CABG Surgery for Heart Attack (BEEFBURGER Trial)
BEEFBURGER Trial Summary
This trial found that in patients without reduced heart function or heart failure, beta-blockers did not have a significant impact on cardiovascular risk after CABG surgery.
BEEFBURGER Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBEEFBURGER Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 157 Patients • NCT02003391BEEFBURGER Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been on beta blocker medication for 6-8 weeks.I had a stroke after heart bypass surgery.Your heart's pumping function is at least 45%, as measured within 6 months of the date of your heart surgery.I am over 18 and have had a coronary artery bypass graft.I have had heart failure with a low heart pumping rate.I cannot commit to regular check-ups.I have had atrial fibrillation or flutter before or around the time of surgery.
- Group 1: Continue beta blocker therapy
- Group 2: De-prescribe beta blocker therapy
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are allowed to join this trial?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was first launched on August 23 2021, is currently recruiting participants. Approximately 200 individuals must be recruited from 1 site."
Could you explain the risks associated with discontinuing beta blocker therapy?
"The safety rating for De-prescribe beta blocker therapy was determined to be a 3, considering the fact that this is an approved Phase 4 trial."
Is this experiment currently accepting participants?
"Affirmative. The information available on clinicaltrials.gov corroborates that this medical trial is currently recruiting participants. This study was initially posted on August 23rd 2021 and the details were last edited on November 8th 2022, with a target of 200 patients over one site."
Share this study with friends
Copy Link
Messenger